Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2017 08:30 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host 2017 First Quarter Financial Results Conference Call on May 18, 2017 at 5:00 p.m. Eastern Time

BASKING RIDGE, N.J., May 09, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company with a therapeutic development pipeline focused...
May 09, 2017 08:30 ET | Source: Northern Superior Resources Inc.

Northern Superior Discovers Two New Gold-Bearing Structures, Phase 1 Drill Program, Croteau Est Gold Property, Québec

SUDBURY, Ontario, May 09, 2017 (GLOBE NEWSWIRE) -- Northern Superior Resources Inc. (“Northern Superior” or the “Company”) (TSXV:SUP), is pleased to announce the discovery of two new gold-bearing...
May 09, 2017 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Receives Approval from Institutional Review Board for Continuation of its Fulvestrant Microcatheter Phase 2 Study

SEATTLE, WA--(Marketwired - May 9, 2017) - Atossa Genetics, Inc. (NASDAQ: ATOS), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods for breast cancer and...
May 09, 2017 08:00 ET | Source: Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals Announces Cerdulatinib Data to be Presented at the International Conference on Malignant Lymphoma (ICML)

SOUTH SAN FRANCISCO, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc.® (Nasdaq:PTLA) today announced that clinical results from the Phase 2 study of cerdulatinib in...
May 09, 2017 08:00 ET | Source: Jounce Therapeutics, Inc.

Jounce Therapeutics Reports First Quarter 2017 Financial Results

- Completed upsized initial public offering raising $117.1 million in gross proceeds -- Presented preclinical data supporting ongoing Phase 1/2 ICONIC study -- Initiated Phase 2 portion of ICONIC...
May 09, 2017 07:30 ET | Source: Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights

DEVON, Pa., May 09, 2017 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative...
May 09, 2017 07:26 ET | Source: Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Updates

LOS ANGELES, CA--(Marketwired - May 9, 2017) - Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a leading developer of novel therapeutic products that...
May 09, 2017 07:00 ET | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics Reports First Quarter 2017 Financial Results

NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system...
May 09, 2017 06:45 ET | Source: Loxo Oncology, Inc.

Loxo Oncology Announces First Quarter 2017 Financial Results

– Larotrectinib Late-Breaking Oral Presentation at ASCO Annual Meeting on June 3, 2017 – – Company to Host ASCO Conference Call and Webcast on June 4, 2017 – – $244.3M in Cash, Cash Equivalents,...
May 09, 2017 06:00 ET | Source: Gemphire Therapeutics

Gemphire Announces First Quarter 2017 Financial Results and Provides Corporate Update

LIVONIA, Mich., May 09, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for...